BioPharma Dive1d
How biotech and pharma teams are reaching LPI ahead of schedule
With the right strategy, reaching LPI ahead of schedule isn’t a myth. Learn how some biotech and pharma teams are achieving ...
Ophthalmology Times1d
Stealth BioTherapeutics reaches 50 percent enrollment target in phase 3 ReNEW study
The ReNEW study for dry AMD is evaluating the efficacy, safety, and pharmacokinetics of daily subcutaneous injections of ...
EurekAlert!3d
Conclusion of global, multicentre trial defines aspirin’s role in reducing colorectal cancer recurrence
Led by Singapore, a 12-year, international, multi-centre, phase 3 clinical trial of aspirin for the secondary prevention of colorectal cancer in over 1,500 patients has been completed and published in ...
UroToday3d
SES AUA 2025: PSA Dynamics from the Phase 3 EMBARK Trial: A Post Hoc Analysis
SESAUA annual meeting featured a prostate cancer session and a presentation by Dr. Paul Sieber discussing a post hoc analysis ...
Clinical Trials Arena on MSN6d
Gilead to launch Phase III once-yearly HIV PrEP trial after Phase I success
Gilead is set to launch a Phase III trial of its once-yearly lenacapavir pre-exposure prophylaxis (PrEP) for human ...